New $38 million study tests if common drugs can extend healthy aging

A groundbreaking $38 million study called VITAL-H is challenging how we approach getting older.

eventVITAL-H

Led by the Barshop Institute at UT Health San Antonio, this clinical trial aims to move medicine beyond just treating diseases after they appear.

orgBarshop Institute

orgUT Health San Antonio

Instead, the goal is to proactively improve 'healthspan'—the number of years we live in good health—by testing if existing, FDA-approved medications can slow down biological aging.

concepthealthspan

Funded by the Advanced Research Projects Agency for Health (ARPA-H), the study will follow 726 adults between 60 and 65.

orgAdvanced Research Projects Agency for Health

Participants will be tested with three drugs: Rapamycin, Dapagliflozin, and Semaglutide.

techRapamycin

techDapagliflozin

techSemaglutide

Historically, longevity research was limited to animal models, but this trial brings those concepts directly to humans.

conceptlongevity

The ultimate ambition is to narrow the gap between our lifespan and our healthspan, ensuring that as we live longer, we also stay more independent and vibrant.

concepthealthspan

By focusing on prevention rather than reaction, this project could transform modern healthcare, making healthy aging an accessible reality rather than an exclusive privilege for the few.

otherhealthcare

🎉

End of article

You read 8 focus sentences.

Challenge Mode

Comprehension Questions

What is the primary objective of the VITAL-H trial?

To determine if existing medications can extend healthspan and delay age-related decline.

To discover entirely new pharmaceutical compounds for rare diseases.

To extend human life expectancy to over 120 years.

Reveal Answer

✓

Correct Choice

To determine if existing medications can extend healthspan and delay age-related decline.

Which agency is providing the funding for this study?

The Advanced Research Projects Agency for Health (ARPA-H).

The National Science Foundation (NSF).

The World Health Organization (WHO).

Reveal Answer

✓

Correct Choice

The Advanced Research Projects Agency for Health (ARPA-H).

How many participants are expected to take part in the study?

726 adults.

Approximately 500 adults.

Over 1,000 adults.

Reveal Answer

✓

Correct Choice

726 adults.

What does the term 'healthspan' refer to?

The medical cost of treating age-related illnesses.

The period of life spent in good health.

The total number of years an individual lives.

Reveal Answer

✓

Correct Choice

The period of life spent in good health.

Why is the VITAL-H study considered a shift in methodology?

It abandons the use of medications in favor of diet.

It focuses solely on genetic modification in aging.

It moves longevity research from animal models to human clinical trials.

Reveal Answer

✓

Correct Choice

It moves longevity research from animal models to human clinical trials.

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.

App Store Google Play